American Society of Addiction Medicine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
American Society of Addiction Medicine (ASAM)
Logo of American Society of Addiction Medicine
MottoTreat Addiction. Save Lives
Formation1954 (1954)[1]
TypeProfessional association
Legal status501(c)(3)[2]
HeadquartersRockville, Maryland[3]
  • United States
Paul Earley, MD[4]
Penny S. Mills, MBA[5]

The American Society of Addiction Medicine (ASAM) is an organization representing medical professionals who specialize in addiction prevention and treatment. The addiction medicine society represents over 6,000 physicians, clinicians, and associated professionals with a focus on addiction and its treatment.[6]


ASAM has its roots in research and clinical traditions that pre-date its founding in the early 1950s, when Ruth Fox, M.D. began regular meetings with other physicians interested in alcoholism and its treatment at the New York Academy of Medicine. In 1954 these physicians established the New York City Medical Society on Alcoholism (later expanded as NYCMSA and Other Drug Dependencies) with Dr. Fox as its first President.

ASAM was admitted to the American Medical Association (AMA) House of Delegates as a voting member in June 1988, and in June 1990 the AMA added addiction medicine (ADM) to its list of designated specialties.

In 1989, to reflect the Society's concern with all drugs of addiction as well as its interest in establishing addiction medicine as part of mainstream medicine, the organization was renamed the American Society of Addiction Medicine (ASAM).


ASAM, founded in 1954, is a professional medical society representing over 6,000 physicians, clinicians and associated professionals in the field of addiction medicine.


ASAM is the largest leading professional society actively seeking to define and expand the field of addiction medicine.[citation needed] ASAM membership offers the opportunity to develop treatment guidelines and protocol, network with peers and attend courses in the field of addiction medicine.[citation needed]

Medical Education and Conferences[edit]

The ASAM Annual Conference - Innovations in Addiction Medicine and Science is a conference on addiction medicine. This event is held annually in April.


ASAM is critical of the current regulatory state of marijuana, holding that there is no such thing as appropriate medical use of the plant cannabis; in 2010, the society published a white paper calling for federal regulations to oversee research and development of cannabis based medicines and issued recommendations for state medical authorities to "...assure that physicians who choose to discuss the medical use of cannabis and cannabis-based products with patients...[a]dhere to the established professional tenets of prr patient care...";[citation needed] in 2012 the society stated that there is no "Medical marijuana" because the plant parts in question fails to meet the standard requirements for approved medicines, that Marijuana has many serious, negative health effects.[citation needed]

Journal of Addiction Medicine[edit]

Published six times per year, the Journal of Addiction Medicine (JAM) is the official journal of the American Society of Addiction Medicine.

The current Editor-in-Chief is Dr. Richard Saitz.

Other publications[edit]

  • The ASAM Criteria, (2013) ISBN 978-1-61702-197-8
  • The ASAM Essentials of Addiction Medicine, (2015), ISBN 9781451194463
  • The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
  • The ASAM Handbook of Addiction Medicine, 2015 ( ISBN 9780190214647)
  • The ASAM Handbook on Pain and Addiction, 2017 ( ISBN 9780190265366)
  • The Principles of Addiction Medicine, sixth edition 2018, ( ISBN 9781496371010)
  • The ASAM Weekly (e-Newsletter)


Term President
1954–1961 Ruth Fox, MD
1961–1963 Stanley Gitlow, MD
1963–1965 Luther A. Cloud, MD
1965–1967 Percy E. Ryberg, MD
1967–1969 Arnold S. Zentner, MD
1969–1971 Ruth Fox, MD
1971–1973 Stanley Gitlow, MD
1973–1975 Maxwell N. Weisman, MD
1975–1977 Charles S. Lieber, MD
1977–1979 Joseph J. Zuska, MD
1979–1981 Sheila B. Blume, MD
1981–1983 LeClair Bissell, MD
1983–1985 Irvin L. Blose, MD
1985–1987 Max A. Schneider, MD
1987–1989 Margaret Bean-Bayog, MD
1989–1991 Jasper G. Chen See, MD
1991–1993 Anthony B. Radcliffe, MD
1993–1995 Anne Geller, MD
1995–1997 David E. Smith, MD
1997–1999 G. Douglas Talbott, MD
1999–2001 Marc Galanter, MD, FASAM
2001–2002 Andrea Barthwell, MD, FASAM
2002–2005 Lawrence S. Brown, Jr., MD
2005–2007 Elizabeth F. Howell, MD
2007–2009 Michael M. Miller, MD
2009–2011 Louis E. Baxter, Sr., MD, FASAM
2011–2013 Donald J. Kurth, MD
2013–2015 Stuart Gitlow, MD, MPH, MBA, DFAPA, DFASAM
2015–2017 R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM
2017-2019 Kelly J. Clark, MD, MBA, DFAPA, DFASAM
2019-2021 Paul Earley, MD
2021-2023 William Haning, MD, DFAPA, DFASAM


  1. ^ "Archived copy". Archived from the original on 2019-06-01. Retrieved 2019-06-01.CS1 maint: archived copy as title (link)
  2. ^ "American Society of Addiction Medicine Inc." Exempt Organization Select Check. Internal Revenue Service. Accessed on May 22, 2016.
  3. ^ "Form 990: Return of Organization Exempt from Income Tax". American Society of Addiction Medicine. Guidestar. December 31, 2014.
  4. ^ "Board of Directors". American Society of Addiction Medicine. Accessed on May 22, 2016.
  5. ^ a b c "ASAM Staff". American Society of Addiction Medicine. Accessed on May 22, 2016.
  6. ^ "ASAM - American Society of Addiction Medicine". Retrieved 2020-05-07.